Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy

S. Marti, X. Muñoz, J. Rios, F. Morell, J. J. Ferrer

Research output: Contribution to journalArticleResearchpeer-review

106 Citations (Scopus)


The aim of this study was to investigate the association between clinical variables and all-cause and respiratory mortality in patients with chronic obstructive pulmonary disease (COPD) undergoing long-term oxygen therapy (LTOT). The authors retrospectively studied a historic cohort of 128 patients with COPD (126 males, mean age ±SD 68.9±9.7 yrs, body mass index (BMI) 25.1 ±4.5 kg·m-2, and forced expiratory volume in one second 25.4±8.8% predicted), who were being treated with long-term oxygen therapy in a tertiary teaching hospital between 1992 and 1999. Comorbidity, assessed with the Charlson Index, was present in 38% of the patients. Vital status and cause of death were assessed through the population death registry. A total of 78 patients (61%) had died by the end of follow-up. Three-year survival was 55%. Death was due to respiratory causes in 77% of cases. On Cox analysis, BMI <25 kg·m-2, comorbid conditions, age ≥70 yrs and cor pulmonale were associated with all-cause mortality. The BMI and comorbidity were the only significant predictive factors when the analysis was restricted to respiratory mortality. In conclusion, body mass index <25 kg·m-2 and comorbidity were predictors of all-cause and respiratory mortality in a cohort of chronic obstructive pulmonary disease patients treated with long-term oxygen therapy. These factors should be taken into account when considering the management and prognosis of these patients.

Original languageAmerican English
Pages (from-to)689-696
Number of pages8
JournalEuropean Respiratory Journal
Issue number4
Publication statusPublished - Apr 2006


  • Chronic obstructive pulmonary disease
  • Comorbidity
  • Mortality
  • Oxygen inhalation therapy
  • Weight loss


Dive into the research topics of 'Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy'. Together they form a unique fingerprint.

Cite this